Corvus Pharmaceuticals, Inc. (CRVS)
10.53
-0.12
(-1.13%)
USD |
NASDAQ |
Oct 23, 16:00
10.50
-0.03
(-0.28%)
After-Hours: 20:00
Corvus Pharmaceuticals Price to Book Value : 3.931 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.931 |
| October 22, 2026 | 3.976 |
| October 21, 2026 | 3.752 |
| October 20, 2026 | 3.819 |
| October 19, 2026 | 3.603 |
| October 16, 2026 | 3.554 |
| October 15, 2026 | 3.677 |
| October 14, 2026 | 3.502 |
| October 13, 2026 | 3.513 |
| October 12, 2026 | 3.752 |
| October 09, 2026 | 3.927 |
| October 08, 2026 | 3.812 |
| October 07, 2026 | 3.886 |
| October 06, 2026 | 3.942 |
| October 05, 2026 | 4.010 |
| October 02, 2026 | 4.069 |
| October 01, 2026 | 4.080 |
| September 30, 2026 | 4.301 |
| September 29, 2026 | 4.390 |
| September 28, 2026 | 4.431 |
| September 25, 2026 | 4.338 |
| September 24, 2026 | 4.405 |
| September 23, 2026 | 4.682 |
| September 22, 2026 | 5.018 |
| September 21, 2026 | 4.637 |
| Date | Value |
|---|---|
| September 18, 2026 | 4.689 |
| September 17, 2026 | 4.685 |
| September 16, 2026 | 4.566 |
| September 15, 2026 | 4.835 |
| September 14, 2026 | 4.894 |
| September 11, 2026 | 4.820 |
| September 10, 2026 | 4.831 |
| September 09, 2026 | 4.976 |
| September 08, 2026 | 5.200 |
| September 04, 2026 | 5.372 |
| September 03, 2026 | 5.469 |
| September 02, 2026 | 5.301 |
| September 01, 2026 | 5.327 |
| August 31, 2026 | 5.242 |
| August 28, 2026 | 5.286 |
| August 27, 2026 | 5.495 |
| August 26, 2026 | 5.499 |
| August 25, 2026 | 5.436 |
| August 24, 2026 | 5.260 |
| August 21, 2026 | 5.398 |
| August 20, 2026 | 5.350 |
| August 19, 2026 | 5.749 |
| August 18, 2026 | 5.536 |
| August 17, 2026 | 5.566 |
| August 14, 2026 | 5.559 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.881 |
Price to Book Value Related Metrics
| Price | 10.53 |
| Earnings Yield | -5.87% |
| Market Cap | 885.79M |